Paris - Delayed Quote EUR

Eurobio Scientific Société anonyme (ALERS.PA)

14.62 -0.12 (-0.81%)
At close: May 28 at 5:28 PM GMT+2

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Denis Fortier CEO, Member of Management Board & Chairman 300.39k -- 1968
Mr. Jean-Michel Carle Grandmougin CCO, GM, Member of Management Board & Director 235.47k -- 1961
Mr. Olivier Bosc Manager of Finance & IT and CFO -- -- --
Ms. Cathie Marsais COO and Operations, Affairs Quality & Regulatory -- -- --
Mr. Maarten Penning Ph.D. CTO and Director of R&D -- -- --
Mr. Eric Pryjda Vice President of Sales & Marketing -- -- --
Mr. Thomas Moreaux CHRO & Ressources Humaines -- -- --
Mr. Thomas Iff Chief Business Officer -- -- --
Ms. Hanneke Merkens CMO, COM and Manager of International Product, Infectious & Transplant -- -- --

Eurobio Scientific Société anonyme

7 avenue de Scandinavie
ZA de Courtaboeuf
Les Ulis, 91940
France
33 1 69 79 64 80 https://www.eurobio-scientific.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
300

Description

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

Corporate Governance

Eurobio Scientific Société anonyme’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 10, 2024 at 3:40 PM UTC

Eurobio Scientific Société anonyme Earnings Date

Recent Events